Skip to main content
Equibles

MOORE CAPITAL MANAGEMENT, LP

Position in REPL — Replimune Group, Inc.

CIK 1448574 NEW YORK, NY
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,441,258
-$938,840 QoQ
Shares Held
130,195
-58.2% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#53
of 199 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names. REPL ranks #25 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 81,700 $15,300,776
2 GMAB
Genmab A/S
 420,487 $11,550,777
3 TECH
BIO-TECHNE Corp
 125,626 $8,875,476
4 IMCR
Immunocore Holdings plc
 274,663 $8,720,550
5 RLAY
Relay Therapeutics, Inc.
 414,005 $7,746,033
6 DYN
Dyne Therapeutics, Inc.
 305,794 $6,791,684
7 PTCT
Ptc Therapeutics, Inc.
 75,588 $6,165,713
8 SLDB
Solid Biosciences Inc.
 603,472 $6,028,685

All Filings in REPL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,441,258 130,195
2026-03-31 $2,380,098 311,124